NCT06053606View on ClinicalTrials.gov

The Impact of Expandable Cryoballoon on Autonomic Control of the Heart

NARecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 10, 2024

Primary Completion Date

December 31, 2026

Study Completion Date

December 31, 2026

Conditions
Paroxysmal Atrial Fibrillation
Interventions
DEVICE

cryoablation of atrial fibrillation using only 28 mm size balloon

all applications in all PVs are done with 28 mm balloon

DEVICE

cryoablation of atrial fibrillation using expandable balloon (28 / 31 mm)

first applications in LSPV and RSPV are done with 31 mm balloon

Trial Locations (1)

50-556

RECRUITING

Institute of Heart Diseases, Wroclaw Medical University, Wroclaw

Sponsors
All Listed Sponsors
lead

Wroclaw Medical University

OTHER

collaborator

Boston Scientific Corporation

INDUSTRY